Basics |
Company: |
AlloVir, Inc. |
IPO Date: |
July 30, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$54.8M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.54 | 4.16%
|
Avg Daily Range (30 D): |
$0.09 | 4.07%
|
Avg Daily Range (90 D): |
$0.05 | 3.88%
|
Institutional Daily Volume |
Avg Daily Volume: |
.02M |
Avg Daily Volume (30 D): |
.02M |
Avg Daily Volume (90 D): |
.01M |
Trade Size |
Avg Trade Size (Sh.): |
5 |
Avg Trade Size (Sh.) (30 D): |
25 |
Avg Trade Size (Sh.) (90 D): |
21 |
Institutional Trades |
Total Inst.Trades: |
346 |
Avg Inst. Trade: |
$1.66M |
Avg Inst. Trade (30 D): |
$3.5M |
Avg Inst. Trade (90 D): |
$3.5M |
Avg Inst. Trade Volume: |
.01M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.01M |
Avg Closing Trade (30 D): |
$3.5M |
Avg Closing Trade (90 D): |
$3.5M |
Avg Closing Volume: |
6K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-.88
|
$-.04
|
$-.05
|
Diluted EPS
|
$-.88
|
$-.04
|
$-.05
|
Revenue
|
$
|
$
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -100.2M
|
$ -4.13M
|
$ -6.08M
|
Operating Income / Loss
|
$ -108.2M
|
$ -5.72M
|
$ -7.77M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 20.38M
|
$ 11.56M
|
$ 14.32M
|
PE Ratio
|
|
|
|
Splits |
Jan 16, 2025:
23:1
|
|